Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
15.56
-0.37 (-2.32%)
Oct 28, 2025, 4:00 PM EDT - Market closed
IART Revenue
Integra LifeSciences Holdings had revenue of $415.61M in the quarter ending June 30, 2025, a decrease of -0.61%. This brings the company's revenue in the last twelve months to $1.62B, up 3.53% year-over-year. In the year 2024, Integra LifeSciences Holdings had annual revenue of $1.61B with 4.47% growth.
Revenue (ttm)
$1.62B
Revenue Growth
+3.53%
P/S Ratio
0.73
Revenue / Employee
$368,912
Employees
4,396
Market Cap
1.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.61B | 68.95M | 4.47% |
| Dec 31, 2023 | 1.54B | -16.09M | -1.03% |
| Dec 31, 2022 | 1.56B | 15.22M | 0.99% |
| Dec 31, 2021 | 1.54B | 170.58M | 12.43% |
| Dec 31, 2020 | 1.37B | -145.69M | -9.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
IART News
- 13 days ago - Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 - GlobeNewsWire
- 20 days ago - Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer - GlobeNewsWire
- 6 weeks ago - Integra LifeSciences Still Recovering From Self-Inflicted Wounds - Seeking Alpha
- 6 weeks ago - Integra LifeSciences Holdings Corporation (IART) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences - GlobeNewsWire
- 3 months ago - Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Integra LifeSciences Reports Second Quarter 2025 Financial Results - GlobeNewsWire